跳至主要内容
临床试验/NL-OMON39468
NL-OMON39468已完成不适用

Effects of melatonin treatment, light therapy, and sleep improvement on psychosocial, cognitive, and behavioural outcomes in children with Delayed Sleep Phase Syndrome and their parents - Melatonin treatment, light therapy, and sleep improvement in children

niversiteit van Amsterdam0 个研究点目标入组 192 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
192

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 17(—)

入选标准

  • - The child is between 7 and 12 years old,
  • - The child has chronic sleep onset problems, which is indicated by:
  • a. complaint of inability to fall asleep at the desired clock time (Sleep onset later than 20:45 h in children aged 7 years and for older children 15 minutes later per year until and including age 12, and a latency between lights-off time and sleep onset (sleep onset latency) of more than 30 minutes),
  • the symptoms are present for at least 4 nights a week, for at least 1 month during a regular
  • school period,
  • - Dim Light Melatonin Onset (DLMO, the clock time at which the endogenous melatonin secretion reaches the threshold of 4 pg/ml) later than 19:45 h in children aged 7 years and for older children 15 minutes later per year until and including age 12,
  • - the sleep problems result in problems with daytime functioning . Children should have the following symptoms:
  • a) sleepiness/tiredness during the day
  • and at least one of the following:
  • b) external behaviour problems
  • c) internal behaviour problems
  • d) problems with functioning at school.

排除标准

  • - pervasive developmental disorder
  • - chronic pain
  • - known disturbed hepatic or renal function
  • - Roter or Dubin-Johnson syndrome
  • - epilepsy
  • - use of stimulants, neuroleptics, benzodiazepines, clonidine, antidepressants, hypnotics, or *-blockers within 4 weeks before enrolment
  • - total IQ <80

研究者

发起方
niversiteit van Amsterdam

相似试验